Literature DB >> 9805134

Noonan syndrome and aortic coarctation.

M C Digilio1, B Marino, F Picchio, D Prandstraller, A Toscano, A Giannotti, B Dallapiccola.   

Abstract

Congenital heart defect (CHD) is present in half of the propositi with Noonan syndrome (NS). Aortic coarctation (AC) is rarely seen in NS, since only three male patients with NS and AC have been previously reported. On the other hand, AC is common in the Ull-rich-Turner syndrome, an aneuploidy disorder and not a mendelian syndrome. In order to evaluate if AC is truly rare in patients with NS, we reviewed our series of 184 propositi with NS and CHD. AC was diagnosed in 16 (8.7%) patients. There were 11 males and 5 females. All had normal chromosomes. Clinical characteristics of the patients are described. Familial occurrence was detected in one girl with NS and AC whose mother and sibs also had NS, but different form of CHDs. Thus, AC is more frequent in NS than previously reported.

Entities:  

Mesh:

Year:  1998        PMID: 9805134

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

Authors:  Talita M Marin; Kimberly Keith; Benjamin Davies; David A Conner; Prajna Guha; Demetrios Kalaitzidis; Xue Wu; Jessica Lauriol; Bo Wang; Michael Bauer; Roderick Bronson; Kleber G Franchini; Benjamin G Neel; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

Review 2.  The role of the protein tyrosine phosphatase SHP2 in cardiac development and disease.

Authors:  Jessica Lauriol; Fabrice Jaffré; Maria I Kontaridis
Journal:  Semin Cell Dev Biol       Date:  2014-09-22       Impact factor: 7.727

3.  Isolated Coarctation of the Aorta: Current Concepts and Perspectives.

Authors:  Ami B Bhatt; Maria R Lantin-Hermoso; Curt J Daniels; Robert Jaquiss; Benjamin John Landis; Bradley S Marino; Rahul H Rathod; Robert N Vincent; Bradley B Keller; Juan Villafane
Journal:  Front Cardiovasc Med       Date:  2022-05-25

4.  Are ECG abnormalities in Noonan syndrome characteristic for the syndrome?

Authors:  R Raaijmakers; C Noordam; J A Noonan; E A Croonen; C J A M van der Burgt; J M T Draaisma
Journal:  Eur J Pediatr       Date:  2008-02-13       Impact factor: 3.183

5.  Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways.

Authors:  Maria I Kontaridis; Wentian Yang; Kendra K Bence; Darragh Cullen; Bo Wang; Natalya Bodyak; Qingen Ke; Aleksander Hinek; Peter M Kang; Ronglih Liao; Benjamin G Neel
Journal:  Circulation       Date:  2008-03-03       Impact factor: 29.690

6.  Noonan syndrome and different morphologic expressions of hypertrophic cardiomyopathy.

Authors:  Efrén Martínez-Quintana; Fayna Rodríguez-González; Paula Junquera-Rionda
Journal:  Pediatr Cardiol       Date:  2012-07-13       Impact factor: 1.655

7.  Clinical manifestations of Noonan syndrome.

Authors:  M Digilio; B Marino
Journal:  Images Paediatr Cardiol       Date:  2001-04

8.  Coarctation of the aorta: a secondary cause of hypertension.

Authors:  L M Prisant; Kwabena Mawulawde; Deepak Kapoor; Clarence Joe
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-06       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.